Literature DB >> 807654

In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes.

R Burton, J Thompson, N L Warner.   

Abstract

A microculture system for in vitro induction of tumour-specific immunity with syngeneic spleen cells and plasma-cell tumours is described. The system generates cytoxic lymphocytes assessed by their ability to lyse 51Cr-labelled target cells in a microcytotoxicity assay. Both the inductive and effector phases are subject to many variables in material and methodology and the optimal conditions are defined in this study. Of particular importance are the responder- to stimulator-cell ratios, the presence of 2-mercaptoethanol, the day of harvest, the method of target-cell 51Cr labelling, and preincubation of the cytotoxic lymphocytes prior to assay.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 807654     DOI: 10.1016/0022-1759(75)90090-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  16 in total

1.  Effects of placental tissue on immunological responses.

Authors:  M Barg; R C Burton; J A Smith; G A Luckenbach; J Decker; G F Mitchell
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

Review 2.  Modulation of antitumor immunity--immunobiologic approaches.

Authors:  R J North; E S Dye; C D Mills; J P Chandler
Journal:  Springer Semin Immunopathol       Date:  1982

3.  An analysis of T lymphocyte subsets in tumour-transplanted mice on the basis of Lyt antigenic markers and functions.

Authors:  P K Lala; I F McKenzie
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

4.  Suppression of antitumor immunity by macrophages in spleens of mice bearing a large MOPC-315 tumor.

Authors:  Q W Ye; M B Mokyr; J M Pyle; S Dray
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

5.  The early appearance of specific cytotoxic T cells in murine gut mucosa.

Authors:  M D Davies; D M Parrott
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

6.  Eradication of a large MOPC-315 tumor in athymic nude mice by chemoimmunotherapy with Lyt2+ splenic T cells from melphalan-treated BALB/c mice bearing a large MOPC-315 tumor.

Authors:  L M Weiskirch; E Barker; M B Mokyr
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

7.  Cytotoxic T cells in small intestine epithelial, lamina propria and lung lymphocytes.

Authors:  M D Davies; D M Parrott
Journal:  Immunology       Date:  1981-10       Impact factor: 7.397

8.  Two tumor models of curative adoptive chemoimmunotherapy using tumor-infiltrated spleen cells with potent antitumor cytotoxicity stimulated by antigen-sharing tumors.

Authors:  M Laude; K L Russo; M B Mokyr; S Dray
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

9.  Specificity of the generation and expression of enhanced anti-plasmacytoma immunity by spleen cells from melphalan-treated MOPC-315 tumor bearers.

Authors:  M B Mokyr; E Barker
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

10.  Antitumor and therapeutic effects of spleen cells from tumor-bearing mice cultured with T cell growth factor and soluble tumor extract.

Authors:  N Kan; K Ohgaki; T Inamoto; H Kodama
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.